Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Recruiting now · Phase 3
Conditions studied: Community-acquired Pneumonia, Influenza, COVID-19
In brief
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to improve outcome of patients admitted to intensive care with community-acquired pneumonia. In addition, REMAP-CAP provides and adaptive research platform for evaluation of multiple treatment modalities in the event of a respiratory pandemic such as COVID-19. REMAP-COVID is a sub-platform of REMAP-CAP that evaluates treatments specific to COVID-19 in the United States of America.
Key facts
- Study ID
- NCT02735707
- Run by
- UMC Utrecht
- People needed
- 20000
- Starts
- 2016-04-11
- Expected to finish
- 2028-02-01
- Last updated by the study team
- 2024-07-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Royal North Shore Hospital — Sydney, New South Wales, Australia (enrolling)
- Westmead Hospital — Westmead, New South Wales, Australia (enrolling)
- University of Florida — Jacksonville, Florida, United States (enrolling)
- Prince of Wales Hospital — Sydney, New South Wales, Australia (enrolling)
- Wollongong Hospital — Sydney, New South Wales, Australia (enrolling)
- University of Illinois Health — Chicago, Illinois, United States (enrolling)
- The Ohio State University Wexner Medical Center — Columbus, Ohio, United States (enrolling)
- Oregon Health and Science University — Portland, Oregon, United States (enrolling)
- University of Pittsburgh Medical Centre — Pittsburgh, Pennsylvania, United States (enrolling)
- University of Michigan — Ann Arbor, Michigan, United States (enrolling)
- Memorial Sloan Kettering Cancer Center — New York, New York, United States (enrolling)
- Bankstown-Lidcombe Hospital — Bankstown, New South Wales, Australia (enrolling)
- Blacktown Hospital — Blacktown, New South Wales, Australia (enrolling)
- Campbelltown Hospital — Campbelltown, New South Wales, Australia (enrolling)
- Sutherland Hospital — Caringbah, New South Wales, Australia (enrolling)
- Concord Hospital — Concord, New South Wales, Australia (enrolling)
- Dubbo Base Hospital — Dubbo, New South Wales, Australia (enrolling)
- Northern Beaches Hospital — Frenchs Forest, New South Wales, Australia (enrolling)
- Nepean Hospital — Kingswood, New South Wales, Australia (enrolling)
- St. George Hospital — Kogarah, New South Wales, Australia (enrolling)
- Liverpool Hospital — Liverpool, New South Wales, Australia (enrolling)
- John Hunter Hospital — Newcastle, New South Wales, Australia (enrolling)
- Canberra Hospital — Canberra, Australian Capital Territory, Australia (enrolling)
- St Vincent's Hospital Sydney — Sydney, New South Wales, Australia (enrolling)
- The Prince Charles Hospital — Brisbane, Queensland, Australia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.